Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · IEX Real-Time Price · USD
4.360
+0.020 (0.46%)
At close: Apr 18, 2024, 1:45 PM
4.500
+0.140 (3.21%)
After-hours: Apr 18, 2024, 4:06 PM EDT
Edesa Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Edesa Biotech stock have an average target of 39, with a low estimate of 21 and a high estimate of 57. The average target predicts an increase of 794.50% from the current stock price of 4.36.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 14, 2024.
Analyst Ratings
The average analyst rating for Edesa Biotech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +381.65% | Feb 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $21 | Strong Buy | Maintains | $70 → $21 | +381.65% | Nov 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +129.36% | Nov 22, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $57 | Strong Buy | Maintains | $57 | +1,207.34% | Oct 12, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $112 → $70 | Strong Buy | Maintains | $112 → $70 | +1,505.50% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.37
from -2.93
EPS Next Year
-1.70
from -2.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.14 | -1.58 | -1.49 |
| Avg | -2.37 | -1.70 | -1.45 |
| Low | -2.74 | -1.79 | -1.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.